These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35116521)

  • 1. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
    Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
    Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes.
    Jia MM; Liang ZJ; Chen Q; Zheng Y; Li LM; Cao XC
    Cancer Biol Med; 2014 Jun; 11(2):123-9. PubMed ID: 25009754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database.
    Zhang J; Wang XX; Lian JY; Song CG
    Oncotarget; 2019 Aug; 10(50):5245-5252. PubMed ID: 31497253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
    Abrams MJ; Koffer PP; Wazer DE; Hepel JT
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes.
    Zhang N; Zhang J; Zhang H; Liu Y; Zhao W; Wang L; Chen B; Moran MS; Haffty BG; Yang Q
    Oncologist; 2019 Dec; 24(12):e1286-e1293. PubMed ID: 31315963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
    Xia LY; Xu WY; Zhao Y
    PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-mastectomy Radiotherapy in T1-2 Breast Cancer Patients With One to Three Lymph Node Metastases: A Propensity Score Matching Analysis.
    Chen M; Huang Y; Leng Z; Yang G; Li F; Yang H; Hou L
    Front Oncol; 2019; 9():1551. PubMed ID: 32117784
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
    Cai W; Zhuang Y; Chen J; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Ho A; Patil S; El-Tamer M
    Ann Surg Oncol; 2014 May; 21(5):1569-74. PubMed ID: 24488216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.
    Shen H; Zhao L; Wang L; Liu X; Liu X; Liu J; Niu F; Lv S; Niu Y
    Tumour Biol; 2016 May; 37(5):6465-75. PubMed ID: 26631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
    Wei J; Jiang Y; Shao Z
    Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
    Zeidan YH; Habib JG; Ameye L; Paesmans M; de Azambuja E; Gelber RD; Campbell I; Nordenskjöld B; Gutiérez J; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Joseph DJ; Crown J; Piccart-Gebhart M; Francis PA
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):316-324. PubMed ID: 29534902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
    Tendulkar RD; Rehman S; Shukla ME; Reddy CA; Moore H; Budd GT; Dietz J; Crowe JP; Macklis R
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e577-81. PubMed ID: 22560546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
    Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
    Front Oncol; 2022; 12():789198. PubMed ID: 35280719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes.
    Ren F; Yang C; Liu J; Feng K; Shang Q; Kang X; Zhang R; Li L; Zhao S; Wang X; Wang X
    Transl Cancer Res; 2024 Feb; 13(2):935-951. PubMed ID: 38482409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
    Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.